Adverse effects of cell-free and concentrated ascites reinfusion therapy for malignant ascites: a single-institute experienceMisato Tsubokura, Hiromichi Matsushita, Ken Kato et al.|BMC Cancer|2022Cited by 16
USEFULNESS OF MEASUREMENT OF CD34-POSITIVE CELL COUNT AT MID-APHERESIS PRODUCT SAMPLING IN PERIPHERAL BLOOD STEM CELL COLLECTIONS. Nakabayashi, Takahiro Fukuda, Minoru Kojima et al.|Japanese Journal of Transfusion and Cell Therapy|2023Cited by 1
Adverse Effects of Cell Free and Concentrated Ascites Reinfusion Therapy (CART) for Malignant Ascites: A Single Institute ExperienceMisato Tsubokura, Hiromichi Matsushita, Hiroto Ishiki et al.|Research Square|2020Cited by 0
A CASE OF DISCOVERING DEVIATION IN TEMPERATURE CONTROL BY CHECKING THE APPEARANCE AT THE TIME OF DELIVERYYuki Kase, Hiromichi Matsushita, Minoru Kojima et al.|Japanese Journal of Transfusion and Cell Therapy|2021Cited by 0
Additional file 1 of Adverse effects of cell-free and concentrated ascites reinfusion therapy for malignant ascites: a single-institute experienceMisato Tsubokura, Hiromichi Matsushita, Yuko Adegawa et al.|Figshare|2022Cited by 0